The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 45.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.222%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 45.50
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Volex wins contract; Engage XR revenue jumps

Thu, 27th Apr 2023 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

4Global PLC - London-based data, services and software for sporting events and the promotion of physical activity - Says revenue in second half of year ended March 31 has been "strong". Expects to report revenue of GBP5.6 million, up from GBP3.6 million a year ago. Adjusted earnings before interest, tax, depreciation and amortisation expected to be in line with market expectations. Says revenue generation profile has been weighted to the second half of the financial year. "While both Services and Technology divisions both performed in the year being reported, the directors are specifically pleased to report Technology revenues continue to grow as the company continues to focus on increasing its recurring revenue as a percentage of total revenue," 4Global adds. In December, the company reported first half revenue of GBP1.4 million, up 10% from GBP1.3 million a year ago.

----------

Cornerstone FS PLC - cloud-based payment provider - Completes sale of Avila House Ltd to Aspire Commerce Ltd following approval from the Financial Conduct Authority. Says it has now received GBP300,000 in cash in consideration for Avila. Also confirms that it began generating revenue under its 12-month software licencing agreement with Aspire in January. Chief Executive James Hickman says: "We are pleased to have completed this sale and to realise value from the disposal of a subsidiary that could no longer contribute to our business. This deal is particularly strong as we are also generating revenue from licencing our platform to the buyer. The proceeds will be used to bolster our existing cash resources as we continue to drive our business forward."

----------

Avacta Group PLC - life sciences company, developing targeted oncology drugs and diagnostics - Says the first patient has been dosed in the US under its investigational new drug application in its phase 1 multi-centre trial evaluating the safety and tolerability of AVA6000. Says AVA6000 is a novel tumour targeted form of doxorubicin. CEO Alastair Smith says: "The US trial sites in New York and Seattle will play a key role, along with other sites in the UK and US, in this multi-centre trial both in the dose escalation phase and in the dose expansion phase which we expect to begin in the second half of the year."

----------

Volex PLC - Basingstoke, England-based electronic components maker - Secures "major new contract" with North American-based automotive manufacturer to supply advanced electric vehicle power products from its manufacturing facility in Tijuana, Mexico. Expects the annualised revenues arising from this contract to exceed USD30 million, with full production anticipated to commence during 2024. "This contract win follows Volex's decision to invest in doubling the capacity of its Tijuana site, supporting customers who want to simplify their supply chains and secure reliable manufacturing services closer to their production locations," Volex says.

----------

Pressure Technologies PLC - Sheffield, England-based group of specialist precision engineering businesses - Says auditor Grant Thornton K LLP requires more time to finalise its audit report due to resource constraints. The audit is for Pressure's accounts for the financial year ended October 1, 2022. The company will therefore not be in a position to publish its audited results by the end of April. Now expects to publish results in mid-May. Expects no change to revenue and operating profit. The company's shares were suspended on April 3 and will remain suspended until the results are published. Back in March, Pressure said an accounting treatment it has applied since financial year 2019 for long-term defence contracts within its Chesterfield Special Cylinders unit is not in compliance with IFRS15, "which requires that all costs incurred in the period relating to the contract should be immediately expensed".

----------

Cohort PLC - Reading, England-based technology company with five businesses serving defence and security sectors - Says wholly owned subsidiary MASS Consultants Ltd has been awarded an extension to the Joint Command & Staff Training contract for UK Strategic Command for a further one year, until July 2025. This contract has a value in over GBP6 million. "Together with other recent contract wins across the group, this contract further underpins our order book and enhances the visibility of future revenues," says CEO Andy Thomis.

----------

Downing Renewables & Infrastructure Trust PLC - investor in solar parks, wind farms and hydroelectric assets - Buys portfolio of operational solar PV assets located in the UK for GBP12.6 million. Says the 13.0 megawatt peak portfolio of two ground-mounted sites and approximately 1,600 commercial and residential installations benefits from high levels of feed-in tariffs and renewable obligation certificate subsidies. Following this acquisition, the Company has deployed substantially all of its remaining cash and expects to draw on its GBP40 million revolving credit facility to make future acquisitions.

----------

Engage XR Holdings PLC - Waterford, Ireland-based virtual reality software and technology group - Reports its trading in the first quarter of 2023 has been in-line with its expectations, noting "strong" revenue growth in the period of 40% against the prior year. Also says period saw "good growth" in Engage XR's pipeline of opportunities. CEO David Whelan says: "After a strong 2022 in terms of revenue growth, we are delighted that this has continued into the current financial year, where we have had an excellent start to 2023. Engage Link is attracting huge interest, and the Fatboy Slim concert was both well reviewed and acted as an incredible demonstration of what can be achieved in Engage Link. We are adding more functionality all the time and have already developed and demonstrated the integration of artificial intelligence into the platform working with Chat GPT and other Open AI protocols. We expect to have AI client offerings later this year, which will completely transform how users communicate, interact and build within the metaverse."

----------

Tower Resources PLC - Africa-focused oil and gas company - provides an update on the activities of its Thali production sharing contract in the Rio Del Rey sedimentary basin, offshore Cameroon. Says it has applied for a one-year extension of the initial exploration period of the production sharing contract. Says discussions continue with rig owners and operators, with the aim to secure rig availability in the third and fourth quarter of this year to drill at NJOM-3. Discussion for a USD7 million term loan is ongoing. Also is discussing asset-level financing with "several parties". Chair & CEO Jeremy Asher says: "We are very pleased with the progress that we are making on the Thali PSC and the NJOM-3 well, and we believe that we are close to having a final schedule for this well, which will be transformational for the company."

----------

International Personal Finance PLC - Leeds, England-based company which offers small, unsecured cash loans - Says all its divisions have started the year well, with the company trading ahead of its internal plans at the end of the first quarter. Delivers customer lending growth of 15% in the first quarter of 2023 against the year prior. Customer receivables end the first quarter at GBP883 million, up 15% year-on-year at constant exchange rates. CEO Gerard Ryan says: "We have delivered strong year-on-year lending and receivables growth and, despite the macroeconomic landscape, we have not seen any discernible impact of the cost-of-living crisis on customer repayment performance across the group." Expects to deliver good lending growth and results ahead of its original plans for the year as a whole.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 May 2024 11:53

IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company developing cancer treatments and diagnostics - Promotes Christina Coughlin to chief executive officer from head of Research & Development. Coughlin has been an Avacta board member since March 2022 and head of R&D since this past February. She replaces Alastair Smith, who steps down on Tuesday after 19 years as CEO. Coughlin was CEO of Cytolmmune Therapeutics, which develops cell therapy solutions from a facility in Puerto Rico. She also has worked at Pfizer Inc and Novartis AG.

Read more
30 Apr 2024 16:30

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Apr 2024 14:26

UK earnings, trading statements calendar - next 7 days

Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Whitbread PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Apr 2024 17:51

TRADING UPDATES: First Tin updates Tellerhauser estimates

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Mar 2024 13:10

Avacta reaches milestone in AVA6000 dose escalation

(Sharecast News) - Avacta Group announced a significant milestone in its phase 1a dose escalation study of AVA6000, its lead 'preCISION' drug, on Thursday.

Read more
21 Mar 2024 10:37

Avacta doses third patient in drug conjugate trial for tumour tissue

(Alliance News) - Avacta Group PLC on Thursday said it dosed the third patient in the first cohort of its phase 1a dose escalation study for its lead preCision drug AVA6000.

Read more
18 Mar 2024 14:31

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - At annual general meeting on Monday, shareholders approved the resolution to issue 23.9 million placing shares and 10.9 million Rex offer share, both at 50 pence each. This raises gross proceeds of around GBP11.9 million and GBP5.4 million respectively. Combined with proceeds from an earlier firm placing and direct subscription, the shares for which were admitted to trading on March 4, Avacta has raised total gross proceeds of GBP31.1 million.

Read more
5 Mar 2024 17:09

EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 12:18

Avacta increases placing size to GBP26 million thanks to strong demand

(Alliance News) - Avacta Group PLC on Thursday said it is increasing its placing to GBP25.7 million, "in light of the strong demand."

Read more
29 Feb 2024 10:27

AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
29 Feb 2024 08:27

Avacta tumbles after raising £25.7m in heavily discounted placing

(Sharecast News) - Healthcare therapeutics company Avacta tumbled on Thursday after a heavily discounted placing.

Read more
28 Feb 2024 20:31

TRADING UPDATES: Avacta plans fundraise to fund clinical development

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Jan 2024 11:18

Avacta appoints new head of research and development

(Sharecast News) - Oncology drugs and diagnostics developer Avacta announced the appointment of Dr Christina Coughlin as its new head of research and development for the therapeutics division on Friday.

Read more
19 Jan 2024 09:11

IN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise"

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Appoints Christina Coughlin as head of research and development. Coughlin, who will take up the position on February 1, has served as a non-executive director of Avacta since March 2022 and was appointed consultant in interim in September 2023. She previously served as chief executive officer of Cytoimmune Therapeutics LLC, a clinical stage biotechnology company focused on novel cancer immunotherapy products. In the new role, Coughlin will oversee clinical and pre-clinical research and development activities for the company's therapeutics division, while retaining her position on as an executive director of Avacta. The company says that Coughlin has been "pivotal" in the development strategy for its AVA6000 tumour-targeted therapy.

Read more
19 Dec 2023 10:24

Avacta appoints new chief business officer

(Sharecast News) - Oncology drugs and diagnostics specialist Avacta Group announced the appointment of Dr Simon Bennett as the chief business officer of its therapeutics division on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.